高盛-益丰药房(603939.SS):业绩回顾:2026年上半年因扩张不及预期营收未达预期,净利润符合预期,维持买入-Yifeng Pharmacy(603939.SS):Earnings review:1H26 revenue miss due to less-than-expected expansion;NP in line;Buy-20260828【6页】

发表回复

后才能评论